medical supply and health care for 2024. The list was made based on three main criteria – financial capacity reflected in the latest financial reports, media reputation, and the results of a survey of ...
Following the COVID-19 pandemic disruptions, which highlighted the fragility of the global supply chains, pharmaceutical companies are compelled to re-evaluate and reinforce their supply chain ...